• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Epidemiology pinpoints cancer risk factors and survival strategies

    Some cancers are on the rise, but the overall U.S

    Phase II trial aims to extend ablation to larger liver tumors

    Hepatocellular (HCC) cancer generally has a poor prognosis and, in contrast to other cancers in the United States, mortality is increasing

    CURE program in eighth year of success

    This year, 50 students participated in the CURE program a training opportunity that offers hands-on research experience to high school and college students with the goal of encouraging careers in cancer research

    Health Communication Core

    The Health Communication Core (HCC) provides evidence-based communication expertise to investigators working in the areas of cancer prevention, control, treatment, and survivorship

    DF/HCC Nodal Awards announced

    DF/HCC offers a multitude of funding opportunities to its members to encourage and enhance the collaborative spirit of research within the Harvard medical community

    DF/HCC members awarded grants amid tight funding environment

    The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives

    DF/HCC / UMB partnership awarded $11 million by NCI

    Dana-Farber/Harvard Cancer Center and the University of Massachusetts Boston have been awarded $11 million over the next five years by the NCI to embolden their strong collaborative cancer research, training, and outreach program

Displaying results 92 to 98 out of 229